JMJD5 Antikörper (AA 151-380)
-
- Target Alle JMJD5 Antikörper anzeigen
- JMJD5 (Jumonji Domain Containing 5 (JMJD5))
-
Bindungsspezifität
- AA 151-380
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser JMJD5 Antikörper ist unkonjugiert
-
Applikation
- ELISA, Immunohistochemistry (IHC)
- Kreuzreaktivität
- Human
- Aufreinigung
- >95%, Protein G purified
- Immunogen
- Recombinant Human JmjC domain-containing protein 5 protein (151-380AA)
- Isotyp
- IgG
- Top Product
- Discover our top product JMJD5 Primärantikörper
-
anti-Jumonji Domain Containing 5 (JMJD5) (AA 36-63), (N-Term) antibody
JMJD5 Reaktivität: Human WB Wirt: Kaninchen Polyclonal RB24972 unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 1-416) antibodyJMJD5 Reaktivität: Human WB, IF Wirt: Maus Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 147-416) antibodyJMJD5 Reaktivität: Human WB, IHC Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (N-Term) antibodyJMJD5 Reaktivität: Human, Meerschweinchen, Pferd, Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 72-121) antibodyJMJD5 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Kaninchen, Affe, Huhn, Schwein WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (C-Term) antibodyJMJD5 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Zebrafisch (Danio rerio), Affe WB Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (Middle Region) antibodyJMJD5 Reaktivität: Human, Maus, Ratte, Rind (Kuh), Meerschweinchen, Pferd, Zebrafisch (Danio rerio), Hund, Kaninchen WB, ChIP Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (C-Term) antibodyJMJD5 Reaktivität: Human, Maus, Ratte WB, IHC (p), EIA Wirt: Kaninchen Polyclonal unconjugated
anti-Jumonji Domain Containing 5 (JMJD5) (AA 36-63), (N-Term) antibodyJMJD5 Reaktivität: Human WB, EIA Wirt: Kaninchen Polyclonal unconjugated
-
- Applikationshinweise
- Recommended dilution: IHC:1:20-1:200,
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, PH 7.4 - Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C,-80 °C
- Informationen zur Lagerung
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Target
- JMJD5 (Jumonji Domain Containing 5 (JMJD5))
- Andere Bezeichnung
- KDM8 (JMJD5 Produkte)
- Synonyme
- jmjd5 antikoerper, JMJD5 antikoerper, 3110005O21Rik antikoerper, Jmjd5 antikoerper, zgc:173863 antikoerper, zgc:91962 antikoerper, RGD1304823 antikoerper, lysine demethylase 8 antikoerper, jumonji domain containing 5 antikoerper, hypothetical protein antikoerper, lysine (K)-specific demethylase 8 antikoerper, KDM8 antikoerper, PTRG_02386 antikoerper, MCYG_00400 antikoerper, CC1G_13927 antikoerper, PGTG_16928 antikoerper, kdm8 antikoerper, Kdm8 antikoerper
- Hintergrund
-
Background: Histone demethylase required for G2/M phase cell cycle progression. Specifically demethylates dimethylated \\\'Lys-36\\\' (H3K36me2) of histone H3, an epigenetic repressive mark, thereby acting as a transcription activator. Regulates expression of CCNA1 (cyclin-A1), leading to regulate cancer cell proliferation.
Aliases: FLJ13798 antibody, JmjC domain-containing protein 5 antibody, JMJD5 antibody, JMJD5 protein antibody, jumonji domain containing 5 antibody, Jumonji domain-containing protein 5 antibody, KDM8_HUMAN antibody, Lysine (K) specific demethylase 8 antibody, Lysine-specific demethylase 8 antibody
- UniProt
- Q8N371
- Pathways
- Chromatin Binding
-
